Literature DB >> 22204747

Which preparation of botulinum toxin a should be used, where should it be injected, and how should its efficacy be assessed?

Christopher R Chapple.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 22204747     DOI： 10.1016/j.eururo.2011.12.005

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  4 in total

Review 1.  Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.

Authors:  Oussama El Yazami Adli; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2014-01       Impact factor: 1.862

2.  Delayed contrast-enhanced MRI to localize Botox after cystoscopic intravesical injection.

Authors:  Mazen Alsinnawi; William Torreggiani; Mazher Sheikh; Arun Thomas; John Donnellan; Robert Flynn; T E D Mcdermott; John Thornhill
Journal:  Int Urol Nephrol       Date:  2015-04-19       Impact factor: 2.370

Review 3.  OnabotulinumtoxinA for the treatment of overactive bladder.

Authors:  Lindsey Cox; Anne P Cameron
Journal:  Res Rep Urol       Date:  2014-07-21

Review 4.  Emerging treatments for overactive bladder: clinical potential of botulinum toxins.

Authors:  Douglas G Tincello; Tina Rashid; Vladimir Revicky
Journal:  Res Rep Urol       Date:  2014-05-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.